Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Pablo Amend"'
Autor:
Patricia Mester, Pablo Amend, Stephan Schmid, Jürgen J. Wenzel, Marcus Höring, Gerhard Liebisch, Sabrina Krautbauer, Martina Müller, Christa Buechler, Vlad Pavel
Publikováno v:
Infectious Disease Reports, Vol 16, Iss 4, Pp 593-607 (2024)
SARS-CoV-2 infection was shown to induce proprotein convertase subtilisin/kexin type 9 (PCSK9) plasma levels in sepsis. Here, we investigate the association between serum PCSK9 levels and disease severity. PCSK9 was measured in serum of 55 controls,
Externí odkaz:
https://doaj.org/article/c4604f97793e4bd3ba35587345a36e89
Autor:
Vlad Pavel, Pablo Amend, Niklas Schmidtner, Alexander Utrata, Charlotte Birner, Stephan Schmid, Sabrina Krautbauer, Martina Müller, Patricia Mester, Christa Buechler
Publikováno v:
Biomedicines, Vol 12, Iss 9, p 2099 (2024)
Background/Objectives: Chemerin is an adipokine involved in inflammatory and metabolic diseases, and its circulating levels have been associated with inflammatory parameters in various patient cohorts. Severe acute respiratory syndrome coronavirus ty
Externí odkaz:
https://doaj.org/article/861eca34df7b435484a0c3cb5f210fd6
Autor:
Vlad Pavel, Ulrich Räth, Stephan Schmid, Sabrina Krautbauer, Dennis Keller, Pablo Amend, Martina Müller, Patricia Mester, Christa Buechler
Publikováno v:
Biomedicines, Vol 12, Iss 5, p 1043 (2024)
Adiponectin is primarily known for its protective role in metabolic diseases, and it also possesses immunoregulatory properties. Elevated levels of adiponectin have been observed in various inflammatory diseases. However, studies investigating adipon
Externí odkaz:
https://doaj.org/article/5130be7e57e24475bf367f24b5ed7331
Autor:
Patricia Mester, Ulrich Räth, Stephan Schmid, Pablo Amend, Dennis Keller, Sabrina Krautbauer, Sofiia Bondarenko, Martina Müller, Christa Buechler, Vlad Pavel
Publikováno v:
Biomedicines, Vol 12, Iss 1, p 125 (2024)
Insulin-like growth factor-binding protein (IGFBP)-2 is a regulator of anabolic pathways, which become inactivated in severe illness. Here, we measured the serum IGFBP-2 levels of COVID-19 patients with moderate and severe disease as well as healthy
Externí odkaz:
https://doaj.org/article/4b9f8ee77e1a4c539c8d5ca3f6405296
Publikováno v:
Viruses, Vol 15, Iss 7, p 1511 (2023)
Proprotein convertase subtilisin/kexin type 9 (PCSK9) reduces low density lipoprotein (LDL) uptake, leading to increased plasma levels of LDL. In addition, PCSK9 has been implicated in inflammation independently of the effects on cholesterol metaboli
Externí odkaz:
https://doaj.org/article/e12fa49b879842ff995e99fcfa06d7d4
Publikováno v:
Biomedicines, Vol 11, Iss 7, p 1779 (2023)
Chemerin is a chemoattractant protein abundantly expressed in hepatocytes. Chemerin exerts pro- and anti-inflammatory effects and acts as a pro-resolving protein. Chemerin levels are low in patients with liver cirrhosis and are increased in sepsis. T
Externí odkaz:
https://doaj.org/article/245d1e7413e443dbb6a5464729720e51
Publikováno v:
Viruses; Volume 15; Issue 7; Pages: 1511
Proprotein convertase subtilisin/kexin type 9 (PCSK9) reduces low density lipoprotein (LDL) uptake, leading to increased plasma levels of LDL. In addition, PCSK9 has been implicated in inflammation independently of the effects on cholesterol metaboli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::da934a3c99e8a91501f6b4ab7dabc319
Publikováno v:
Biomedicines; Volume 11; Issue 7; Pages: 1779
Chemerin is a chemoattractant protein abundantly expressed in hepatocytes. Chemerin exerts pro- and anti-inflammatory effects and acts as a pro-resolving protein. Chemerin levels are low in patients with liver cirrhosis and are increased in sepsis. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::2d37561b313d9c40832695cbee160c29